SEC Filings | Harvard Bioscience, Inc.

Filing date	Form	Description	View
Aug 14, 2002	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001104659-02-004157.pdf 0001104659-02-004157.rtf 0001104659-02-004157.xls
Aug 12, 2002	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000912057-02-031189.pdf 0000912057-02-031189.rtf
Jul 29, 2002	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	View HTML 0000912057-02-028813.pdf 0000912057-02-028813.rtf
Jul 29, 2002	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000912057-02-028861.pdf 0000912057-02-028861.rtf
Jul 23, 2002	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000912057-02-028165.pdf 0000912057-02-028165.rtf
Jul 19, 2002	8-K	Report of unscheduled material events or corporate event	View HTML 0000912057-02-027941.pdf 0000912057-02-027941.rtf
Jul 19, 2002	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000912057-02-027943.pdf 0000912057-02-027943.rtf
Jul 18, 2002	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000912057-02-027810.pdf 0000912057-02-027810.rtf
May 14, 2002	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001104659-02-002264.pdf 0001104659-02-002264.rtf 0001104659-02-002264.xls
Apr 19, 2002	ARS	An annual report to security holders	View HTML 9999999997-02-024863.pdf 9999999997-02-024863.rtf

Data provided by Kaleidoscope.